Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs GeneDx Holdings Corp (WGS) Price & Performance

Cemex S.A.B. de C.V. Sponsored ADRTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Cemex S.A.B. de C.V. Sponsored ADR vs GeneDx Holdings Corp — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.84B), while GeneDx Holdings Corp trades at $67.73 (market cap $2.04B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 6.8× GeneDx Holdings Corp's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and GeneDx Holdings Corp for 19 Days on average.

CXWGS
Market Cap
$13.84B$2.04B
Volume
6,589,714659,215
Sector
Basic MaterialsHealth
52-Week High
$13.55$167.51
52-Week Low
$9.12$34.51
Typical Hold Time
0 Days19 Days
Enterprise Value
$19.83B$2.08B
Dividend Yield
1.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cemex S.A.B. de C.V. Sponsored ADR

No Aura AI signal available yet.

GeneDx Holdings Corp

GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.

The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CX
100% Buy0% Sell
Avg holding period · 0 Days
WGS
53% Buy47% Sell
Avg holding period · 19 Days

About Cemex S.A.B. de C.V. Sponsored ADR

Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.

Read more on CX →

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS →